Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer.

Lundgren, Per-Olof; Tribukait, Bernhard; Kjellman, Anders; Norming, Ulf; Jagarlmudi, Kiran; Gustafsson, Ove

Lundgren, Per-Olof; Tribukait, Bernhard; Kjellman, Anders; Norming, Ulf; Jagarlmudi, Kiran; Gustafsson, Ove.

Lundgren PO; Department of Clinical Science, Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Tribukait B; Department of Oncology-Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden.
Kjellman A; Department of Clinical Science, Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
Norming U; Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden.
Jagarlmudi K; Department of Anatomy, Physiology, and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Gustafsson O; Research and Development Division, AroCell AB, Uppsala, Sweden.

Prostate ; 82(8): 911-916, 2022 06.

Article en En | MEDLINE | ID: mdl-35294068

Asunto(s)

Neoplasias de la Próstata; Timidina Quinasa; Biomarcadores; Biomarcadores de Tumor; Estudios de Casos y Controles; Humanos; Masculino

Palabras clave

prognosis; prostate cancer; thymidine kinase

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Timidina Quinasa Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google